How is Eribulin Intravenous Route dosed?
The recommended dose for metastatic breast cancer is 1.4 mg/m^2 given as an intravenous infusion over 2 to 5 minutes on days 1 and 8 of each 21-day cycle. For metastatic liposarcoma, the dose is 0.58 mg/m^2 given as an intravenous infusion over 2 to 5 minutes on days 1, 8, and 15 of each 28-day cycle. Please consult with your doctor or healthcare provider for the specific dosing information tailored to your individual needs and medical history.
What is the dosage form of Eribulin Intravenous Route?
The dosage form of Eribulin Intravenous Route is a solution.
What medications are contraindication with Eribulin Intravenous Route?
Eribulin Intravenous Route may interact with certain medications, including heart rhythm medications, chemotherapy medications, antifungal medications, and corticosteroids. It should not be given to patients with congenital long QT syndrome. It is important to inform your doctor about any medications you are taking to avoid potential interactions.
How is Eribulin Intravenous Route administered?
Eribulin Intravenous Route is administered by a nurse or other trained health professional in a hospital or cancer treatment center. The medicine is given through a needle placed in one of the veins. It is important to follow the instructions of the healthcare professional administering the medication.
What are common precautions when taking Eribulin Intravenous Route?
Common precautions when taking Eribulin Intravenous Route include informing your doctor about your medical history, following your doctor's instructions, using the medicine exactly as prescribed, having the injection given by a trained health professional, and monitoring your heart rhythm during and after the infusion. Self-administration is not recommended.